The life-saving diabetic medication insulin, developed at the University of Toronto 100 years ago, was the first biologic therapy - a protein to treat disease. A century later, a new biologic therapy also developed by researchers at U of T has potential to reverse a common complication of diabetes.
» New antibody therapy may reverse diabetic retinopathy and other eye conditions
In eye surgery for cataract, the lens refilling method could allow to maintain or restore the lens's accommodation of the lens, i.e. the ability to adjust its refractive power flexibly. So far, however, this method has not yet been clinically successful. The Laser Zentrum Hannover e.V. (LZH) is now...
» Sharp vision with exchanged eye lens: LZH works on improved lens refilling
Information technology can make life easier in many areas – including research. In medicine, for example, it is still standard practice to evaluate microscopy images of tissue sections by hand. Microscopic images of tissue sections can now be analyzed much more easily – with an innovative digital...
» New analysis tool of microscopic images with Deepflash
An international collaboration of scientists publishing in Nature Reviews Disease Primers advocate for a new way of thinking about and finding treatments for age-related macular degeneration (AMD)—the developed world’s leading cause of severe vision impairment for people aged 55 and older.
» Age-Related Macular Degeneration Revisited in Nature Reviews Disease Primers
An international research team has shown that optogenetic therapy has helped to partially regain visual function in a patient with retinitis pigmentosa. This is a milestone towards a gene therapy that could restore vision.
» Optogenetic Methods Restore Partial Vision in a Blind Patient
